---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-062031"
form_type: "8-K"
ticker: "NUVB"
cik: "0001811063"
company_name: "Nuvation Bio Inc."
filed_at: "2025-03-25T23:59:59+00:00"
generated_at: "2026-05-24T05:57:16.026498+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Nuvation Bio enters commercial supply agreement with Asymchem for taletrectinib drug product

## Summary
- Asymchem will be non-exclusive supplier of taletrectinib drug product; Nuvation retains right to use alternate manufacturers.
- Orders must be placed at least 180 days before delivery; cancellation subject to tiered fees.
- Initial term is 5 years, auto-renews for consecutive 3-year terms unless non-renewed.
- Company may terminate without cause on 30 days' notice; each party may terminate for material breach or insolvency.

## SEC filing metadata
- accession: 0001193125-25-062031
- form_type: 8-K
- ticker: NUVB
- cik: 0001811063
- company_name: Nuvation Bio Inc.
- filed_at: 2025-03-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1811063/000119312525062031/0001193125-25-062031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1811063/000119312525062031/d908716d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-062031
- JSON: https://secwatch.observer/filing/0001193125-25-062031.json
- Plain text: https://secwatch.observer/filing/0001193125-25-062031.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.